Thermo Fisher Scientific Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 8c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
April 24, 2019 6:05 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $6.12 billion versus the consensus estimate of $6.02 billion.
First quarter revenue increased to $6.12 billion.First quarter GAAP diluted earnings per share (EPS) increased 41% to $2.02.First quarter adjusted EPS increased 12% to $2.81.Launched a range of new products, including two Thermo Scientific instruments for materials analysis the Nicolet Summit FTIR spectrometer and the Helios 5 DualBeam scanning electron microscope and in specialty diagnostics, received FDA clearance for a new ImmunoCAP... More